The website also includes the research team’s assessment of the quality of the individual models. It includes enhanced versions of the protein structures when possible.
“We have carefully analyzed the available models of SARS-CoV-2 proteins and present the results with the aim of helping the broad biomedical community. Structural models are ultimately the interpretation of the original researchers and sometimes are suboptimal. This is why a second set of eyes to validate important structures is so crucial,” Minor said in a news release.
Read the full story on our sister site R&D World.
Filed Under: Genomics/Proteomics, Infectious Disease